| Product NDC: | 15054-0090 |
| Proprietary Name: | Somatuline Depot |
| Non Proprietary Name: | lanreotide acetate |
| Active Ingredient(s): | 90 mg/.3mL & nbsp; lanreotide acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 15054-0090 |
| Labeler Name: | Ipsen Biopharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022074 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071114 |
| Package NDC: | 15054-0090-1 |
| Package Description: | 1 POUCH in 1 CARTON (15054-0090-1) > 1 SYRINGE in 1 POUCH > .3 mL in 1 SYRINGE |
| NDC Code | 15054-0090-1 |
| Proprietary Name | Somatuline Depot |
| Package Description | 1 POUCH in 1 CARTON (15054-0090-1) > 1 SYRINGE in 1 POUCH > .3 mL in 1 SYRINGE |
| Product NDC | 15054-0090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lanreotide acetate |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20071114 |
| Marketing Category Name | NDA |
| Labeler Name | Ipsen Biopharmaceuticals, Inc. |
| Substance Name | LANREOTIDE ACETATE |
| Strength Number | 90 |
| Strength Unit | mg/.3mL |
| Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |